题名 | Long-term outcome of a phase II trial using immunomodulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy in the treatment of prostate cancer | 链接 | http://link.springer.com/article/10.1007/s13566-015-0239-y |
http://link.springer.com/article/10.1007/s13566-015-0239-y |